Skip to main content
Fig. 5 | Cardiovascular Diabetology

Fig. 5

From: Metabolically-inactive glucagon-like peptide-1(9–36)amide confers selective protective actions against post-myocardial infarction remodelling

Fig. 5

Effect of GLP-1(9–36) on myocardial inflammation post-MI. Representative LV sections stained for a CD45 and b F4/80, together with mean quantification data by analysis of 10 high power fields per section (n = 5–6). LV mRNA expression of cytokines c IL-1β, d IL-6, e MCP-1, and f TGF-β3 by real-time RT-PCR (n = 5–6). White columns, sham, black columns, MI mean ± SEM. **P < 0.01, ***P < 0.001 versus corresponding sham; P < 0.05, †††P < 0.001 versus corresponding MI

Back to article page